Skip to main content
. 2016 Feb 2;55(12):3882–3902. doi: 10.1002/anie.201505863

Figure 1.

Figure 1

Development of HMG‐CoA reductase inhibitors for the treatment of cardiovascular disease. CoA=coenzyme A, HMG=3‐hydroxy‐3‐methylglutaryl.